Molecule Details
| InChIKey | CTSPAMFJBXKSOY-UHFFFAOYSA-N |
|---|---|
| Canonical SMILES | Cc1c2ccncc2c(C)c2c1[nH]c1ccccc12 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.21 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB17026 |
|---|---|
| Drug Name | Ellipticine |
| CAS Number | 519-23-3 |
| Groups | experimental |
| ATC Codes | nan |
| Description | Ellipticine is a potent antineoplastic agent.[A252992] |
Categories: Alkaloids Antineoplastic Agents Carbazoles Enzyme Inhibitors Heterocyclic Compounds, Fused-Ring Indole Alkaloids Indoles Indolizidines Indolizines Secologanin Tryptamine Alkaloids Uncoupling Agents
Cross-references: BindingDB: 50004233 ChEBI: 4776 CHEMBL123 ChemSpider: 3100 C09154 Wikipedia: Ellipticine ZINC: ZINC000001846592